Intravenous Gammaglobulin for Sickle Cell Pain Crises

Clinical trial NCT01757418 · COMPLETED

Trial details

NCT number: NCT01757418
Sponsor: Albert Einstein College of Medicine
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease Pain

Start date: 2008-11-01
Primary completion: 2024-12-18
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.